Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/EBIT

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 37.39-0.150.25-0.25-0.17

What is the latest EV/EBIT ratio of MANKIND PHARMA ?

The latest EV/EBIT ratio of MANKIND PHARMA is 37.39 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar202437.39
Mar2023-0.15
Mar20220.25
Mar2021-0.25
Mar2020-0.17

How is EV/EBIT of MANKIND PHARMA Trending?

Years EV/EBIT % Change
Mar2024 37.39
Positive
Mar2023 -0.15
Negative
Mar2022 0.25
Positive
Mar2021 -0.25
Negative
Mar2020 -0.17 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/EBIT ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹97,727.4 Cr -0.4% -7.8% 9.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,420.0 Cr -0.2% -2.9% 12.6% Stock Analytics
DIVIS LABORATORIES ₹177,572.0 Cr 0.3% 6.5% 49% Stock Analytics
CIPLA ₹123,329.0 Cr 1.1% 1.8% -1.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,396.0 Cr -0.2% 9.5% 12.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,956.0 Cr 1.9% 0.4% 14% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-0.4%

-7.8%

9.9%

SENSEX

-0.8%

-0.9%

6.9%


You may also like the below Video Courses